STUDY OBJECTIVES: Few population-based, longitudinal studies have examined risk factors for persistent insomnia, and the results are inconsistent. Furthermore, none of these studies have examined the role of polysomnographic (PSG) variables such as sleep duration or sleep apnea on the persistence of insomnia. DESIGN: Representative longitudinal study. SETTING: Sleep laboratory. PARTICIPANTS: From a random, general population sample of 1741 individuals of the adult Penn State Cohort, 1395 were followed-up after 7.5 years. MEASUREMENTS: Individuals underwent one-night PSG and full medical evaluation at baseline and a telephone interview at follow-up. PSG sleep duration was analyzed as a continuous variable and as a categorical variable: < 6 h sleep (short sleep duration) and ≥ 6 h sleep (longer sleep duration). RESULTS: The rates of insomnia persistence, partial remission, and full remission were 44.0%, 30.0%, and 26.0%, respectively. Objective short sleep duration significantly increased the odds of persistent insomnia as compared to normal sleep (OR = 3.19) and to fully remitted insomnia (OR = 4.92). Mental health problems at baseline were strongly associated with persistent insomnia as compared to normal sleep (OR = 9.67) and to a lesser degree compared to fully remitted insomnia (OR = 3.68). Smoking, caffeine, and alcohol consumption and sleep apnea did not predict persistent insomnia. CONCLUSIONS: Objective short sleep duration and mental health problems are the strongest predictors of persistent insomnia. These data further support the validity and clinical utility of objective short sleep duration as a novel marker of the biological severity of insomnia.
STUDY OBJECTIVES: Few population-based, longitudinal studies have examined risk factors for persistent insomnia, and the results are inconsistent. Furthermore, none of these studies have examined the role of polysomnographic (PSG) variables such as sleep duration or sleep apnea on the persistence of insomnia. DESIGN: Representative longitudinal study. SETTING: Sleep laboratory. PARTICIPANTS: From a random, general population sample of 1741 individuals of the adult Penn State Cohort, 1395 were followed-up after 7.5 years. MEASUREMENTS: Individuals underwent one-night PSG and full medical evaluation at baseline and a telephone interview at follow-up. PSG sleep duration was analyzed as a continuous variable and as a categorical variable: < 6 h sleep (short sleep duration) and ≥ 6 h sleep (longer sleep duration). RESULTS: The rates of insomnia persistence, partial remission, and full remission were 44.0%, 30.0%, and 26.0%, respectively. Objective short sleep duration significantly increased the odds of persistent insomnia as compared to normal sleep (OR = 3.19) and to fully remitted insomnia (OR = 4.92). Mental health problems at baseline were strongly associated with persistent insomnia as compared to normal sleep (OR = 9.67) and to a lesser degree compared to fully remitted insomnia (OR = 3.68). Smoking, caffeine, and alcohol consumption and sleep apnea did not predict persistent insomnia. CONCLUSIONS: Objective short sleep duration and mental health problems are the strongest predictors of persistent insomnia. These data further support the validity and clinical utility of objective short sleep duration as a novel marker of the biological severity of insomnia.
Entities:
Keywords:
Insomnia; mental health; persistence; polysomnography; short sleep duration
Authors: T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda Journal: Psychiatry Clin Neurosci Date: 2001-06 Impact factor: 5.188
Authors: Stuart F Quan; Ronit Katz; Jean Olson; William Bonekat; Paul L Enright; Terry Young; Anne Newman Journal: Am J Med Sci Date: 2005-04 Impact factor: 2.378
Authors: Diane S Lauderdale; Kristen L Knutson; Lijing L Yan; Paul J Rathouz; Stephen B Hulley; Steve Sidney; Kiang Liu Journal: Am J Epidemiol Date: 2006-06-01 Impact factor: 4.897
Authors: A N Vgontzas; C Tsigos; E O Bixler; C A Stratakis; K Zachman; A Kales; A Vela-Bueno; G P Chrousos Journal: J Psychosom Res Date: 1998-07 Impact factor: 3.006
Authors: Barry Krakow; Dominic Melendrez; Samuel A Lee; Teddy D Warner; Jimmy O Clark; David Sklar Journal: Sleep Breath Date: 2004-03 Impact factor: 2.816
Authors: Alexandros N Vgontzas; Duanping Liao; Edward O Bixler; George P Chrousos; Antonio Vela-Bueno Journal: Sleep Date: 2009-04 Impact factor: 5.849
Authors: Megan R Crawford; Diana A Chirinos; Toni Iurcotta; Jack D Edinger; James K Wyatt; Rachel Manber; Jason C Ong Journal: J Clin Sleep Med Date: 2017-07-15 Impact factor: 4.062
Authors: Eun Lee; Hyong Jin Cho; Richard Olmstead; Myron J Levin; Michael N Oxman; Michael R Irwin Journal: Sleep Date: 2013-11-01 Impact factor: 5.849
Authors: Subhajit Chakravorty; H Y Katy Siu; Linden Lalley-Chareczko; Gregory K Brown; James C Findley; Michael L Perlis; Michael A Grandner Journal: Prim Care Companion CNS Disord Date: 2015-12-31